Centre Hospitalier de Pau

Pau, Pyrénées-Atlantiques 64046

1 studies enrolling now · 4 studies all time

What they study most

Breast Cancer, Ulcerative Colitis, Ulcerative Colitis Chronic

Studies at this site

• A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence — Recruiting now
• A Study of Mirikizumab (LY3074828) in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) — Completed